Bacille Calmette Guérin (BCG) can induce Kawasaki disease-like features in programmed death-1 (PD-1) gene knockout mice

Clinical and Experimental Rheumatology

Volumn 29, Issue 4, 2011, Pages 743-750

  Chun, Jin Kyong ^a   Jeon, Bo Young ^a   Kang, Dong Won ^b   Kim, Dong Soo ^a  

^a Yonsei University College of Medicine   (South Korea)

^b Kwandong University College of Medicine   (South Korea)

Author keywords

Coronary arterial disease; Gene; Inflammation; Mucocutaneous lymph node syndrome; Programmed death 1

Indexed keywords

BCG VACCINE; HEAT SHOCK PROTEIN 65; APOPTOSIS REGULATORY PROTEIN; BACTERIAL PROTEIN; CHAPERONIN; HEAT SHOCK PROTEIN 65, MYCOBACTERIUM; HEAT-SHOCK PROTEIN 65, MYCOBACTERIUM; MEMBRANE ANTIGEN; PDCD1 PROTEIN, MOUSE;

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERY; ARTERY INTIMA PROLIFERATION; ARTICLE; BILIARY ARTERY; CAROTID ARTERY; CLINICAL FEATURE; CONTROLLED STUDY; ERYTHEMA; FEMALE; FEVER; GALLBLADDER DISEASE; GALLBLADDER HYDROPS; GENE; HEART; HEPATIC ARTERY; INFLAMMATORY CELL; KIDNEY; KNOCKOUT MOUSE; LIVER; MALE; MOUSE; MUCOCUTANEOUS LYMPH NODE SYNDROME; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROGRAMMED DEATH 1 GENE; RENAL ARTERY; SKIN EXFOLIATION; STAPHYLOCOCCUS AUREUS; SWELLING; WILD TYPE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; CORONARY BLOOD VESSEL; DISEASE MODEL; GENETICS; HEPATOBILIARY SYSTEM; IMMUNOLOGY; MICROBIOLOGY; MOUSE MUTANT; MYCOBACTERIUM BOVIS; PATHOLOGY; SPLEEN; T LYMPHOCYTE; VASCULARIZATION;

ANIMALS; ANTIGENS, SURFACE; APOPTOSIS REGULATORY PROTEINS; BACTERIAL PROTEINS; BILIARY TRACT; CHAPERONIN 60; CORONARY VESSELS; DISEASE MODELS, ANIMAL; FEMALE; HEPATIC ARTERY; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; MICE, KNOCKOUT; MUCOCUTANEOUS LYMPH NODE SYNDROME; MYCOBACTERIUM BOVIS; RENAL ARTERY; SPLEEN; STAPHYLOCOCCUS AUREUS; T-LYMPHOCYTES;

EID: 80055084115     PISSN: 0392856X     EISSN: 1593098X     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Newburger JW, Takahashi M, Gerber MA et al.: Diagnosis, treatment, and long-term management of Kawasaki disease: a statement for health professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, American Heart Association. Pediatrics 2004; 114: 1708-33.
2. Cheung YF, Huang GY, Chen SB et al.: Inflammatory gene polymorphisms and susceptibility to kawasaki disease and its arterial sequelae. Pediatrics 2008; 122: 608-14.
3. Yang K, Li D, Luo M, Hu Y: Generation of HSP60-specific regulatory T cell and effect on atherosclerosis. Cell Immunol 2006; 243: 90-5.
4. Yeung RS: Lessons learned from an animal model of Kawasaki disease. Clin Exp Rheumatol 2007; 25: S69-71.
5. Kim DS: Kawasaki disease. Yonsei Med J 2006; 47: 759-72.
6. Lehman TJ: Can we prevent long term cardiac damage in Kawasaki disease? Lessons from Lactobacillus casei cell wall-induced arteritis in mice. Clin Exp Rheumatol 1993; 11: S3-6.
7. Chun JK, Kang DW, Yoo BW, Shin JS, Kim DS: Programmed death-1 (PD-1) gene polymorphisms lodged in the genetic predispositions of Kawasaki Disease. Eur J Pediatr 2010; 169: 181-5.
8. Gotsman I, Grabie N, Dacosta R, Sukhova G, Sharpe A, Lichtman AH: Proatherogenic immune responses are regulated by the PD-1/PD-L pathway in mice. J Clin Invest 2007; 117: 2974-82.
9. Grabie N, Gotsman I, Dacosta R et al.: Endothelial programmed death-1 ligand 1 (PD-L1) regulates CD8+ T-cell mediated injury in the heart. Circulation 2007; 116: 2062-71.
10. Nishimura H, Nose M, Hiai H, Minato N, Honjo T: Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carrying immunoreceptor. Immunity 1999; 11: 141-51.
11. Nishimura H, Okazaki T, Tanaka Y et al.: Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science 2001; 291: 319-22.
12. Okazaki T, Honjo T: PD-1 and PD-1 ligands: from discovery to clinical application. Int Immunol 2007; 19: 813-24.
13. Shibata Y, Ohata H, Yamashita M et al.: Immunologic response enhances atherosclerosis-type 1 helper T cell (Th1)-to-type 2 helper T cell (Th2) shift and calcified atherosclerosis in Bacillus Calmette-Guerin (BCG)-treated apolipoprotein E-knockout (apo E-/-) mice. Transl Res 2007; 149: 62-9.
14. George J, Afek A, Gilburd B, Shoenfeld Y, Harats D: Cellular and humoral immune responses to heat shock protein 65 are both involved in promoting fatty-streak formation in LDL-receptor deficient mice. J Am Coll Cardiol 2001; 38: 900-5.
15. Mandal K, Foteinos G, Jahangiri M, Xu Q: Role of antiheat shock protein 60 autoantibodies in atherosclerosis. Lupus 2005; 14: 742-6.
16. Mandal K, Jahangiri M, Xu Q: Autoimmune mechanisms of atherosclerosis. Handb Exp Pharmacol 2005: 723-43.
17. Grover A, Taylor J, Troudt J et al.: Mycobacterial infection induces the secretion of high-mobility group box 1 protein. Cell Microbiol 2008; 10: 1390-404.
18. Sheikhi A, Nazarian M, Khademal-Melleh A et al.: In-vitro effects of Mycobacterium bovis BCG-lysate and its derived heat shock proteins on cytokines secretion by blood mononuclear cells of rheumatoid arthritis patients in comparison with healthy controls. Int Immunopharmacol 2008; 8: 887-92.
19. Cho SN, Hwang JH, Park S et al.: Factors affecting transformation efficiency of BCG with a Mycobacterium-Escherichia coli shuttle vector pYUB18 by electroporation. Yonsei Med J 1998; 39: 141-7.
20. Freeman AF, Crawford SE, Cornwall Ml, Garcia Fl, Shulman ST, Rowley AH: Angiogenesis in fatal acute Kawasaki disease coronary artery and myocardium. Pediatr Cardiol 2005; 26: 578-84.
21. Lehman TJ: Animal models of Kawasaki disease. Prog Clin Biol Res 1987; 250: 149-57.
22. Tkahashi K, Oharaseki T, Wakayama M, Yokouchi Y, Naoe S, Murata H: Histopathological features of murine systemic vasculitis caused by Candida albicans extract-an animal model of Kawasaki disease. Inflamm Res 2004; 53: 72-7.
23. Yeung RS: Kawasaki disease: update on pathogenesis. Curr Opin Rheumatol 2010; 22: 551-60.
24. Lau AC, Duong TT, Ito S, Yeung RS: Matrix metalloproteinase 9 activity leads to elastin breakdown in an animal model of Kawasaki disease. Arthritis Rheum 2008; 58: 854-63.
25. Onouchi Y: Molecular genetics of Kawasaki disease. Pediatr Res 2009; 65: 46R-54R.
26. Onouchi Y, Gunji T, Burns JC et al.: ITPKC functional polymorphism associated with Kawasaki disease susceptibility and formation of coronary artery aneurysms. Nat Genet 2008; 40: 35-42.
27. Kuniyuki S, Asada M: An ulcerated lesion at the BCG vaccination site during the course of Kawasaki disease. J Am Acad Dermatol 1997; 37: 303-4.
28. Nakamura T, Yamamura J, Sato H, Kakinuma H, Takahashi H: Vasculitis induced by immunization with Bacillus Calmette-Guerin followed by atypical mycobacterium antigen: a new mouse model for Kawasaki disease. FEMS Immunol Med Microbiol 2007; 49: 391-7.
29. Van Eden W, Thole JE, Van Der Zee R et al.: Cloning of the mycobacterial epitope recognized by T lymphocytes in adjuvant arthritis. Nature 1988; 331: 171-3.
30. Yokota S, Tsubaki K, Kuriyama T et al.: Presence in Kawasaki disease of antibodies to mycobacterial heat-shock protein HSP65 and autoantibodies to epitopes of human HSP65 cognate antigen. Clin Immunol Immunopathol 1993; 67: 163-70.
31. Crispin JC, Oukka M, Bayliss G et al.: Expanded double negative T cells in patients with systemic lupus erythematosus produce IL-17 and infiltrate the kidneys. J Immunol 2008; 181: 8761-6.
32. Freeman GJ, Long AJ, Iwai Y et al.: Engagement of the PD-1 immunoinhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med 2000; 192: 1027-34.
33. Blank C, Brown I, Marks R, Nishimura H, Honjo T, Gajewski TF: Absence of programmed death receptor 1 alters thymic development and enhances generation of CD4/CD8 double-negative TCR-transgenic T cells. J Immunol 2003; 171: 4574-81.